| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses and other current assets | 707 | |||
| Inventory | 2,552 | |||
| Restricted cash | 100 | |||
| Notes receivable - vyome | 605 | |||
| Cash and cash equivalents | 4,123 | |||
| Accounts and other receivables (net of allowance for doubtful accounts of 858 and 918 respectively) | 775 | |||
| Total current assets | 8,862 | |||
| Property and equipment, net | 30 | |||
| Other assets | 29 | |||
| Operating lease right-of-use assets | 79 | |||
| Deferred tax asset, net | 28 | |||
| Total assets | 9,028 | |||
| Accrued and other liabilities | 1,586 | |||
| Operating lease liabilities, current | 104 | |||
| Accounts payable | 1,346 | |||
| Warranty liability, current | 163 | |||
| Total current liabilities | 3,199 | |||
| Common stock warrant liability | 0 | |||
| Total liabilities | 3,199 | |||
| Accumulated deficit | -643,860 | |||
| Additional paid-in capital | 649,798 | |||
| Accumulated other comprehensive loss | -109 | |||
| Total stockholders' equity (deficit) | 5,829 | |||
| Total liabilities and stockholders' equity (deficit) | 9,028 | |||
ReShape Lifesciences Inc. (RSLS)
ReShape Lifesciences Inc. (RSLS)